Research

Clinical spectrum of high-titre GAD65 antibodies February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/33563803/

Autoimmune encephalitis: proposed best practice recommendations for diagnosis, acute-, symptomatic-, and long-term management. March 5, 2021

We are excited to report the first international best practice recommendations for  the management of autoimmune encephalitis. The papers result from the hard work and collaboration between 68 AEA Clinicians Network members from 17 countries, initiated and led by Dr. Hesham Abboud. These recommendations will be of great value to AE patients and clinicians all […]

Outcomes after AE – #AskMeAboutAE March 10, 2021

At the WED Conference we heard Dr. Tom Pollak talk about how after encephalitis you need to establish a new relationship with your body and brain. He cited research that after encephalitis, people are twice as likely to develop an anxiety disorder, nearly three times as likely to become depressed, and 114 times as likely […]

AE Alliance financially supports and facilitates research May 4, 2021

A great example of AE Alliance facilitating research is the recently published ‘Best Practice Recommendations for diagnosis, acute-, symptomatic-, and long-term management of Autoimmune Encephalitis’. The recommendations result from the hard work and collaboration between 68 AEA Clinicians Network members from 17 countries, initiated and led by Dr. Hesham Abboud (University Hospitals, OH). These recommendations […]

We Got A Match! May 7, 2021

The Research Network funds research that has a direct impact on those affected by AE. We have two generous donors that will match any donation you make to the Research Network, up to $15,000.  With your support last year, we are investing in three impactful AE studies! We will announce these grant recipients on Tuesday May […]

The 2021 AEA Community Seed Grant winners May 11, 2021

Last year we launched the Research Network at the start of the COVID-19 pandemic. A year later, we are still in the midst of the pandemic but seeing the light at the end of the tunnel. With your support in 2020, we can financially support three research studies focused on the diagnosis, management, and outcomes […]

Novel therapeutics and biomarker discovery May 12, 2021

Over the past 20 years, significant advances have improved our understanding of diagnosis, treatment, and underlying causes of AE. The number of new publications has increased dramatically in the past few years. And here, we will share some recent advances made in the area of novel therapeutics and biomarker discovery. Sell at al., Autoimmune encephalitis: […]

Meet Dr. Soon-Tae Lee! May 14, 2021

Dr. Soon-Tae Lee (Seoul National University Hospital – South-Korea) has been awarded the AEA Community Seed Grant to investigate the Development of optimal clinical approaches in seronegative autoimmune encephalitis. Learn more about his study and how this will affect those affected with seronegative autoimmune encephalitis (AE). You have been awarded the AEA Community Seed Grant, can […]